These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 12967138)

  • 1. Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.
    Kuo ML; Hwang HS; Sosnay PR; Kunugi KA; Kinsella TJ
    Cancer J; 2003; 9(4):277-85. PubMed ID: 12967138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of ribonucleotide reductase in transfected human KB cells increases their resistance to hydroxyurea: M2 but not M1 is sufficient to increase resistance to hydroxyurea in transfected cells.
    Zhou BS; Hsu NY; Pan BC; Doroshow JH; Yen Y
    Cancer Res; 1995 Mar; 55(6):1328-33. PubMed ID: 7882331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting ribonucleotide reductase as a target to enhance radiation and chemotherapy anti-tumor activity.
    Sznol M
    Cancer J; 2003; 9(4):247-50. PubMed ID: 12967134
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression of ribonucleotide reductase after ionizing radiation in human cervical carcinoma cells.
    Kuo ML; Kinsella TJ
    Cancer Res; 1998 May; 58(10):2245-52. PubMed ID: 9605773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.
    Zhou B; Liu X; Mo X; Xue L; Darwish D; Qiu W; Shih J; Hwu EB; Luh F; Yen Y
    Cancer Res; 2003 Oct; 63(20):6583-94. PubMed ID: 14583450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human cancer cell growth by inducible expression of human ribonucleotide reductase antisense cDNA.
    Chen S; Zhou B; He F; Yen Y
    Antisense Nucleic Acid Drug Dev; 2000 Apr; 10(2):111-6. PubMed ID: 10805162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential.
    Zhou BS; Tsai P; Ker R; Tsai J; Ho R; Yu J; Shih J; Yen Y
    Clin Exp Metastasis; 1998 Jan; 16(1):43-9. PubMed ID: 9502076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of different response to ionizing irradiation in isogenic head and neck cancer cell lines.
    Todorovic V; Prevc A; Zakelj MN; Savarin M; Brozic A; Groselj B; Strojan P; Cemazar M; Sersa G
    Radiat Oncol; 2019 Nov; 14(1):214. PubMed ID: 31775835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osalmid, a Novel Identified RRM2 Inhibitor, Enhances Radiosensitivity of Esophageal Cancer.
    Tang Q; Wu L; Xu M; Yan D; Shao J; Yan S
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1368-1379. PubMed ID: 32763454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of deoxyribonucleoside triphosphate pool sizes in ribonucleotide reductase cDNA transfected human KB cells.
    Zhou BS; Ker R; Ho R; Yu J; Zhao YR; Shih J; Yen Y
    Biochem Pharmacol; 1998 May; 55(10):1657-65. PubMed ID: 9634002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable suppression of the R2 subunit of ribonucleotide reductase by R2-targeted short interference RNA sensitizes p53(-/-) HCT-116 colon cancer cells to DNA-damaging agents and ribonucleotide reductase inhibitors.
    Lin ZP; Belcourt MF; Cory JG; Sartorelli AC
    J Biol Chem; 2004 Jun; 279(26):27030-8. PubMed ID: 15096505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modifications of the radiosensitivity of a renal cancer cell line as a consequence of stable TIMP-1 overexpression.
    Smyth A; Reid HM; Baker AH; McGlynn H
    Int J Radiat Biol; 2007 Jan; 83(1):13-25. PubMed ID: 17357436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea and trimidox enhance the radiation effect in human pancreatic adenocarcinoma cells.
    Leyden D; Ahmed N; Hassan HT
    Anticancer Res; 2000; 20(1A):133-8. PubMed ID: 10769645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
    Raju U; Nakata E; Mason KA; Ang KK; Milas L
    Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavopiridol potentiates the cytotoxic effects of radiation in radioresistant tumor cells in which p53 is mutated or Bcl-2 is overexpressed.
    Hara T; Omura-Minamisawa M; Kang Y; Cheng C; Inoue T
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1485-95. PubMed ID: 18640498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of β-Catenin Decreases the Radiosensitivity of Human Nasopharyngeal Carcinoma CNE-2 Cells.
    He H; Lin K; Su Y; Lin S; Zou C; Pan J; Zhou Y; Chen C
    Cell Physiol Biochem; 2018; 50(5):1929-1944. PubMed ID: 30396174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ribonucleotide reductase M2 subunit in gastric cancer and effects of RRM2 inhibition in vitro.
    Morikawa T; Hino R; Uozaki H; Maeda D; Ushiku T; Shinozaki A; Sakatani T; Fukayama M
    Hum Pathol; 2010 Dec; 41(12):1742-8. PubMed ID: 20825972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel HSP90 inhibitors, NVP-AUY922 and NVP-BEP800, radiosensitise tumour cells through cell-cycle impairment, increased DNA damage and repair protraction.
    Stingl L; Stühmer T; Chatterjee M; Jensen MR; Flentje M; Djuzenova CS
    Br J Cancer; 2010 May; 102(11):1578-91. PubMed ID: 20502461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ribonucleotide reductase subunit M2 enhances the radiosensitivity of metastatic pancreatic neuroendocrine tumor.
    Chow Z; Johnson J; Chauhan A; Jeong JC; Castle JT; Izumi T; Weiss H; Townsend CM; Schrader J; Anthony L; Yang ES; Evers BM; Rychahou P
    Cancer Lett; 2024 Aug; 596():216993. PubMed ID: 38801884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RPA1 downregulation enhances nasopharyngeal cancer radiosensitivity via blocking RAD51 to the DNA damage site.
    Zhang Z; Huo H; Liao K; Wang Z; Gong Z; Li Y; Liu C; Hu G
    Exp Cell Res; 2018 Oct; 371(2):330-341. PubMed ID: 30144445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.